title: Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients.
abstract: Long-chain 3-hydroxyacyl-coenzyme A (CoA) dehydrogenase is one of three enzyme activities of the mitochondrial trifunctional protein. We report the clinical findings of 13 patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. At presentation the patients had had hypoglycemia, cardiomyopathy, muscle hypotonia, and hepatomegaly during the first 2 years of life. Seven patients had recurrent metabolic crises, and six patients had a steadily progressive course. Two patients had cholestatic liver disease, which is uncommon in beta-oxidation defects. One patient had peripheral neuropathy, and six patients had retinopathy with focal pigmentary aggregations or retinal hypopigmentation. All patients were homozygous for the common mutation G1528C. However, the enoyl-CoA hydratase and 3-ketoacyl-CoA thiolase activities of the mitochondrial trifunctional protein were variably decreased in skin fibroblasts. Dicarboxylic aciduria was detected in 9 of 10 patients, and most patients had lactic acidosis, increased serum creatine kinase activities, and low serum carnitine concentration. Neuroradiologically there was bilateral periventricular or focal cortical lesions in three patients, and brain atrophy in one. Only one patient, who has had dietary treatment for 9 years, is alive at the age of 14 years; all others died before they were 2 years of age. Recognition of the clinical features of long-chain 3-hydroxyacyl-CoA deficiency is important for the early institution of dietary management, which may alter the otherwise invariably poor prognosis.
authors.affiliation: Department of Child Neurology, Children's Hospital, University of Helsinki, Finland.
authors.forename: T
authors.initials: T
authors.lastname: Tyni
authors.forename: A
authors.initials: A
authors.lastname: Palotie
authors.forename: L
authors.initials: L
authors.lastname: Viinikka
authors.forename: L
authors.initials: L
authors.lastname: Valanne
authors.forename: M K
authors.initials: MK
authors.lastname: Salo
authors.forename: U
authors.initials: U
authors.lastname: von Döbeln
authors.forename: S
authors.initials: S
authors.lastname: Jackson
authors.forename: R
authors.initials: R
authors.lastname: Wanders
authors.forename: N
authors.initials: N
authors.lastname: Venizelos
authors.forename: H
authors.initials: H
authors.lastname: Pihko
mesh_terms: D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000172:deficiency*; D009202:Cardiomyopathies / Q000209:etiology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology; D007223:Infant; D007231:Infant, Newborn; D008052:Lipid Metabolism, Inborn Errors / Q000150:complications* / Q000178:diet therapy / Q000235:genetics; D008107:Liver Diseases / Q000209:etiology; D008297:Male; D009123:Muscle Hypotonia / Q000209:etiology; D009154:Mutation; D012164:Retinal Diseases / Q000209:etiology
chemical_list: D015094:3-Hydroxyacyl CoA Dehydrogenases